NewsRest of WorldMajor Cannabis Strides For New Zealand?

Major Cannabis Strides For New Zealand?

-

THIS will be a significant year for New Zealand as medicinal cannabis is legalised and the nation holds a vote on whether or not to legalise recreational use.

From April 1, 2020, all general practitioners can prescribe medical cannabis without oversight from a specialist.

Commercial licences for crop cultivation will be available from the summer and with over 200 firms holding hemp licences – and over 20 holding medical cannabis research licenses – demand is likely to be strong.

Business is already exploring the opportunities in New Zealand with Nelson-based business, Medical Kiwi, signing deals with UK distributors Liberty Herbal Technologies and Vitality CBD.

Vitality CBD is a leading UK CBD brand with a full range of products including including sprays, drops, skin cream, balms, and e-liquids.

Its range is currently sold across the UK including supermarket giant Tesco, pharmacy chain, Boots and other health stores.

The partnership with Liberty Herbal Technologies will allow medical cannabis users access to its non-combustion Hapac inhaler.

Liberty is a subsidiary of UK stock market company Ananda Developments. The Hapac uses a  ‘heat, not burn technology ‘ and can be used with measured doses of medicinal cannabis in small packages.

Last May Prime Minister Jacinda Ardern announced the country would be holding a referendum on the legalisation of cannabis which will take place on September 19, this year.



Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Thought Leaders Acquisition Of mellow Set To Accelerate Growth Across UK, Europe, And Asia Footprint

THE CBD world is set with a massive shake-up this week as Thought Leaders, the US cannabis & CBD investment company,...

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis...

European Cannabis Market Leader Bloomwell Group Secures $10m Investment

The Bloomwell Group has successfully closed a seed funding round of over $10 million dollars—the highest publicly known seed investment...

German Hemp Farm Numbers Up 900% In Seven Years – As industry Calls For Post-Election Reform

THE number of German farms growing industrial hemp has hit 863 – the highest figure since the federal republic...

US Company Set To Launch UK Medical Cannabis Study In Partnership With Manchester University

A GROUND-BREAKING human pilot study centred on the University of Manchester could provide answers to using cannabis as a...

Must read

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science,...

You might also likeRELATED
Recommended to you